SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001079973-17-000385
Filing Date
2017-07-10
Accepted
2017-07-10 17:05:34
Documents
5
Period of Report
2017-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A opgen_8ka.htm 8-K/A 31021
2 EXHIBIT 4.1 ex4x1.htm EX-4.1 117876
3 EXHIBIT 10.1 ex10-1.htm EX-10.1 96977
4 EXHIBIT 10.2 ex10x2.htm EX-10.2 56367
5 EXHIBIT 10.3 ex10-3.htm EX-10.3 62364
  Complete submission text file 0001079973-17-000385.txt   365936
Mailing Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37367 | Film No.: 17958409
SIC: 8071 Services-Medical Laboratories